J&T Biotech intends to allocate 25 million yuan towards the establishment of a biomedical investment fund, in partnership with Guangzhou Nanyue Aoyang Fund Management Co., Ltd. and Guangzhou Nanyue Fund Group Co., Ltd. The total size of the fund is set at 50.01 million yuan. The fund's primary focus will be on investing in biomedical projects that are in their early to mid-stage development. The fund's lifecycle spans 7 years, divided into an initial 4-year investment period followed by a 3-year exit period. J&T Biotech, as a limited partner, will contribute 49.99% of the capital. Notably, this investment does not qualify as a related transaction nor a significant asset reorganization.